Get the latest Science News and Discoveries

Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Related news:

AI-Designed Drug Makes Patients' Blood Look Biologically Younger, Study Shows

Phase 1 Study Supports Recommended Phase 3 Dose for Investigational EGFR x HER3 Antibody-Drug Conjugate in EGFR-Mutated Lung Cancer

25 years after 9/11, study finds neighborhood environment may influence frailty, PTSD, and depression risk among World Trade Center responders